Introduction
Differences in the metabolism of neoplastic cells and normal cells originate from the fact that tumor cells gain energy not by aerobic phosphorylation from the tricarboxylic acid cycle but rather by aerobic glycolysis, a phenomenon known as Warburg's effect [1] . Several possible explanations for the selective biochemical processes of neoplastic cells have been suggested. In order to adapt to hypoxic microenvironments caused by oxygen deprivation as a result of the uncontrollable proliferation of neoplastic cells, tumor cells employ the mechanism that consumes the least oxygen, aerobic glycolysis. In addition, the genes that activate aerobic glycolysis may be subjected to different regulating mechanisms in tumors, resulting in altered expression [2, 3] . As a key process in aerobic glycolysis, glucose uptake into the tumor cells is increased and Glut-1 acts as a glucose transporter ( fig. 1 ).
Increased expression of Glut-1 results in an increase in glucose uptake into cells and in generation of lactate by glycolysis, leading to intracellular acidosis. To prevent acidosis, the expression of carbonic anhydrase IX (CAIX) is increased, as is the expression of pyruvate dehydrogenase kinase 1 (PDK1) in order to suppress mitochondrial respiration. In addition, the expression of macrophage migration inhibitory factor (MIF) is increased to prevent cellular senescence induced by reactive oxygen species [4] [5] [6] [7] [8] [9] [10] [11] .
Overexpression of Glut-1 during the neoplastic process has been reported in human carcinomas. Overexpression of Glut-1 has been shown to be associated with high-grade tumors, poorly differentiated tumors, tumor invasion, and tumor metastasis [12] [13] [14] [15] . Glut-1 overexpression also has been shown to be associated with poor prognosis in oral squamous cell carcinoma [16] , nonsmall cell lung cancer [17] , pulmonary adenocarcinoma [18] , and thyroid cancer [19] , as well as with metastasis in gastric cancer [20] and cervical cancer. [21] .
In the previous gene expression profile study, breast carcinomas were classified into the following five molecular subtypes: luminal A, luminal B, HER-2, normal breast-like, and basal-like [22] . Apart from these five molecular subtypes, estrogen receptor (ER)-, progesterone receptor (PR)-, and HER-2-negative carcinomas were defined clinically as triple-negative breast cancer (TNBC) [23] . Previous studies regarding the role of metabolismrelated proteins in breast cancer have shown that overexpression of Glut-1 is correlated with high grade [24, 25] , proliferative activity [26, 27] , poor differentiation [27] , and poor prognosis [28] , and overexpression of CAIX is correlated with high grade [29] , metastatic breast cancer cell lines [30] , and poor prognosis [31] [32] [33] . Accordingly, since the HER-2 type and basal-like type of breast cancer exhibit high-grade histology, increased proliferative activity, and areas of geographic tumor necrosis, increased expression of metabolism-related proteins in these specific types of breast cancer is to be expected [34] [35] [36] [37] [38] [39] . However, a limited number of studies regarding the expression of metabolism-related proteins according to the molecular subtypes of breast cancer have been conducted [40] . The purpose of this study was to investigate the expression of metabolism-related proteins such as Glut-1 and CAIX according to breast carcinoma subtypes and to determine the implications of these expression patterns.
Materials and Methods

Patient Selection
From the Department of Pathology at Severance Hospital, we retrieved tissue samples collected from patients with invasive ductal breast carcinoma that were archived between January 2000 and December 2001. This study was approved by the Institutional Review Board of Severance Hospital. Formalin-fixed and paraffin-embedded tissue specimens from 276 cases of primary breast cancer were included. All archival hematoxylin and eosin (H&E)-stained slides for each case were reviewed by two pathologists (J.S. Koo and J. Choi). Histological grade was assessed using the Nottingham grading system [41] . The clinical parameters that were evaluated for each tumor included patient age at initial diagnosis, lymph node status, local recurrence, systemic recurrence, and patient survival. Overview of aerobic glycolysis-related proteins in cancer cell metabolism. Several factors, including hypoxia, growth factor (IGF-1), and oncogene activation (cmyc), activate HIF-1 ␣ , leading to increases in the expression of Glut-1 in the cell membrane, the uptake of glucose, and the generation of lactate by glycolysis. The generation of lactate results in intracellular acidosis. The expression of CAIX increases to prevent intracellular acidosis, and the expression of PDK1 increases to decrease mitochondrial respiration. In addition, the expression of MIF increases to prevent cell senescence induced by reactive oxygen species.
Tissue Microarray A representative area was selected on each H&E-stained slide and a corresponding spot was marked on the surface of the paraffin block. Using a biopsy needle, the selected area was punched out and a 3-mm tissue core was placed into a 6 ! 5 recipient block. The tissue of the invasive tumor was extracted. Two tissue cores were extracted to minimize extraction bias. Each tissue core was assigned a unique tissue microarray location number that was linked to a database containing other clinicopathologic data.
Immunohistochemistry
The antibodies used for immunohistochemistry in this study are shown in table 1 . All immunostaining was performed using formalin-fixed, paraffin-embedded tissue sections. Briefly, 5-m-thick sections were obtained with a microtome, transferred onto adhesive slides, and dried at 62 ° C for 30 min. After incubation with primary antibodies, immunodetection was performed with biotinylated anti-mouse immunoglobulin, followed by peroxidase-labeled streptavidin using a labeled streptavidin biotin kit with 3,3 -diaminobenzidine chromogen as the substrate. The primary antibody incubation step was omitted in the negative control. Slides were counterstained with Harris hematoxylin.
Interpretation of Immunohistochemical Staining
All immunohistochemical markers were assessed by light microscopy. A cut-off value of 1% or more of positively stained nuclei was used to define ER and PR positivity [42] . HER-2 staining was analyzed according to the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guidelines using the following categories: 0 = no immunostaining; 1+ = weak incomplete membranous staining in less than 10% of tumor cells; 2+ = complete membranous staining, either uniform or weak in at least 10% of tumor cells, and 3+ = uniformly intense membranous staining in at least 30% of tumor cells. HER-2 immunostaining was considered positive when strong (3 + ) membranous staining was observed, whereas cases with 0-1+ staining were regarded as negative [43] . Cases with 2+ HER-2 expression were evaluated for HER-2 amplification by fluorescent in situ hybridization (FISH). The immunostained slides were scored according to the percentage or intensity of tumor cells exhibiting nuclear (c-myc and HIF-␣ ), cytoplasmic [insulin-like growth factor (IGF)-1, c-myc, Glut-1, MIF, CAIX, PDK1, HIF-␣ , and cytokeratin (CK) 5/6], and membranous epidermal growth factor receptor (EGFR) staining. Immunohistochemical stain results for EGFR, PDK1, c-myc, CAIX, and IGF-1 were evaluated based on the intensity of expression (0 = negative, 1 = weak, 2 = moderate, and 3 = strong). Moderate or intense staining was considered positive. Results for HIF-␣ , MIF, and CK5/6 were considered positive when more than 10% of the tumor cells were stained. The results for Glut-1 were scored according to the percentage of tumor cells with Glut-1 positivity as follows: low (less than 50%) and high (more than 50%).
FISH Analysis
Invasive tumors were examined on H&E-stained slides and FISH was subsequently performed on the tested tumor using a PathVysion HER-2 DNA Probe Kit (Vysis, Downers Grove, Ill., USA) according to the manufacturer's instructions. The HER-2 gene copy number on the slides was evaluated using an epifluorescence microscope (Olympus, Tokyo, Japan). At least 60 tumor cell nuclei in three separate regions were investigated for HER-2 and chromosome 17 signals. HER-2 gene amplification was determined according to ASCO/CAP guidelines [43] . An absolute HER-2 gene copy number lower than 4 or an HER-2 gene/chromosome 17 copy number ratio ( HER-2 /Chr17 ratio) of less than 1.8 was considered HER-2 negative. An absolute HER-2 copy number between 4 and 6 or an HER-2 /Chr17 ratio between 1.8 and 2.2 was considered HER-2 equivocal. An absolute HER-2 copy number greater than 6 or an HER-2 /Chr17 ratio higher than 2.2 was considered HER-2 positive.
Tumor Phenotype Classification Using Surrogate Markers
In this study, we classified breast cancer phenotypes according to immunohistochemistry results for ER, PR, HER-2, and FISH 
Statistical Analysis
Data was analyzed using SPSS for Windows, version 12.0 (SPSS Inc., Chicago, Ill., USA). For the determination of statistical significance, Student's t test and Fisher's exact test were used for continuous and categorical variables, respectively. p ! 0.05 was considered statistically significant. Kaplan-Meier survival curves and log-rank statistics were employed to evaluate the time to tumor recurrence. Multivariate regression analysis was performed using the Cox proportional hazards model.
Results
Patient Characteristics
The clinicopathologic characteristics of 276 patients, which comprised 97 (35.1%) cases of TNBC, 25 (9.1%) cases of the HER-2 type, 33 (12.0%) cases of luminal B, and 121 (43.8%) cases of the luminal A type, are summarized in table 2 . The TNBC and HER-2 types had higher histologic grades (p ! 0.001), higher tumor stage (p = 0.002), higher tumor recurrence rates (p ! 0.001), and a higher number of patient deaths (p = 0.002).
Metabolic Signature according to Molecular Subtype of Breast Cancer
Metabolism-related protein expression according to the molecular subtype of breast cancer is summarized in table 3 and figure 2 . The HER-2 type showed higher rates of positivity for IGF-1 (p = 0.020), HIF-1 ␣ (p = 0.005), and MIF (p ! 0.001). The TNBC type showed higher rates of Glut-1 overexpression and positive expression of CAIX (p ! 0.001 and p = 0.012, respectively), whereas the rate of CAIX expression in the tumor stroma was the lowest (p = 0.012). The luminal A type had the lowest rates of expression of IGF-1, HIF-1 ␣ , and Glut-1. The patterns of metabolism-related protein expression in the basal-like type and non-basal-like type TNBCs are summarized in table 4 . A total of 33 cases of the basal type (34.0%) and 64 cases of the non-basal-like type (66.6%) were studied. The rates of high Glut-1 expression and CAIX positivity were higher in the basal-like type compared with the non-basal-like type (p = 0.010 and p ! 0.001, respectively). 
The Impact of Metabolism-Related Proteins on Disease-Free Survival and Overall Survival
The relationships between the expression of metabolism-related proteins and disease-free survival (DFS) and overall survival (OS) are summarized in table 6 . HIF-1 ␣ positivity was correlated with a shorter DFS and OS (p ! 0.001), and high Glut-1 expression was correlated with a shorter DFS (p = 0.028). Multivariate Cox regression analysis was used to identify clinicopathologic and immunohistochemical parameters affecting patient survival. Parameters associated with a shorter DFS included younger age ( ^ 35 vs. 1 35, p = 0.014, OR = 3.285, 95% CI 1.268-8.501), high T stage (T1 vs. T2-3, p = 0.018, OR = 
Discussion
We investigated the expression of cancer cell metabolism-related proteins according to the molecular subtypes of breast cancer defined by surrogate immunohistochemistry. The expression of HIF-1 ␣ was associated with the HER-2 subtype (p = 0.005), a high histologic grade (p = 0.038), a high T stage (p = 0.006), lymph node metastasis (p = 0.003), ER negativity (p = 0.004), and PR negativity (p = 0.032), which was consistent with previous results that showed that HIF-1 ␣ is correlated with a high histologic grade, ER negativity, and PR negativity [29, 44] .
The association between the expression of HIF-1 ␣ and ER and PR negativity may be explained by several mechanisms. Since it has been reported that hypoxia decreases the expression of hormone receptors [45] , it is possible that the expression of HIF-1 ␣ induced by hypoxia results in the loss of hormone receptors. Another explanation is related to the fact that the loss of hormone receptors is a known characteristic of aggressive breast carcinomas exhibiting high proliferative activity, which tends to generate hypoxic areas where the expression of HIF-1 ␣ is increased [29] . However, HIF-1 ␣ seems to have a stronger association with the HER-2 subtype than the TNBC subtype with a high histologic grade, ER negativity, and PR negativity, and this result is supported by the fact that HIF-1 ␣ protein expression is increased via the HER-2 signaling pathway in breast carcinoma [46] .
In this study, the expression of HIF-1 ␣ was not strongly associated with HER-2 positivity per se, but it was associated with the HER-2 subtype. This finding suggests that HIF-1 ␣ expression is not associated with the luminal B subtype (ER+, PR+, and HER-2+), although it was associated with the HER-2 subtype (ER-, PR-, and HER-2+). We are unsure of the underlying mechanism for this difference, but it may be because factors other than HER-2 expression status could also affect HIF-1 expression. Previous studies have suggested that the expression patterns of HIF-1 ␣ reflect different mechanisms. It has been reported that perinecrotic or focal patterns of expression reflect HIF-1 ␣ overexpression induced by severe hypoxia [47] and that diffuse patterns of expression reflect HIF-1 ␣ overexpression by HER-2 [46] , HIF-1 ␣ gene amplification [48] , or mutation [49] rather than hypoxia. In this study, we were unable to compare results directly with previous studies since a diffuse pattern of HIF-1 ␣ expression was not noted in more than 50% for any tumor. MIF expression was strongly associated with the HER-2 subtype and HER-2 positivity (p ! 0.001). A previous study demonstrated a positive correlation between MIF expression and HER-2 expression [50] , which was consistent with the results of our study, whereas MIF expression was correlated with ER and PR positivity in another study [51] . Thus, additional research is required to elucidate the role of MIF in breast cancer.
Glut-1 high expression was associated with TNBC type (p ! 0.001), high histologic grade (p ! 0.001), absence of lymph node metastasis (p = 0.006), ER negativity (p ! 0.001), and PR negativity (p ! 0.001) in this study. Previous studies have shown that in breast cancer Glut-1 overexpression is associated with high histologic grade, high proliferative activity, poor differentiation, BRCA1-related breast cancer, ER negativity, PR negativity, and the basal-like subtype [24-27, 33, 47, 52] , and the results are consistent with those of this study. The expression of CAIX was associated with TNBC type (p = 0.012), high histologic grade (p = 0.019), and ER negativity (p = 0.008), and these results are consistent with previous studies showing that the expression of CAIX in breast cancer is correlated with a high histologic grade, BRCA1-related breast cancer, ER negativity, PR negativity, and the basallike subtype [31] [32] [33] 47] . The expression of Glut-1 and that of CAIX were associated with similar parameters, consistent with a previous study that showed a highly positive correlation between Glut1 expression and CAIX expression [30] . The expression of Glut-1 and that of CAIX were closely related in this study (p ! 0.001, data not shown).
The expression of HIF-1 ␣ was not related with that of either Glut-1 or CAIX in this study. A previous study using invasive breast cancer tissue was also unable to identify a relationship between the expression of HIF-1 ␣ and Glut-1 or CAIX [30, 40, 53, 54] . Although both Glut-1 and CAIX are known target genes of HIF-1 ␣ as part of the metabolic process, there was no association between HIF-1 ␣ and their expression levels. One possible explanation for this lack of association is the difference in the halflives of HIF-1 ␣ and Glut-1/CAIX. HIF-1 ␣ is undetectable a few minutes after re-oxygenation, whereas Glut-1 and CAIX persist due to their relative stabilities [54, 55] . Another possible explanation is that the expression of Glut-1 and CAIX may be regulated by mechanisms other than HIF-1 ␣ . The expression of Glut-1 may be increased by inhibitors of oxidative phosphorylation such as mitochondrial inhibitors [56] . In addition, CAIX is known to be activated by the phosphatidylinositol-3-kinase (PI3K) pathway [57] and the mitogen-activated protein kinase (MAPK) pathway [58] . Glut-1 and CAIX expression was highest in the TNBC type, which seems to most closely resemble the glycolytic and acid-resistant phenotype. The glycolytic and acid-resistant phenotype exhibits the most powerful adaptive advantage since it uses glycolysis to supply energy to tumors with a high proliferative activity, thereby enabling continuous tumor growth. Active glycolysis results in intracellular acidosis, which usually leads to acid-mediated cell death. However, overexpression of CAIX, such as in the TNBC type, neutralizes the acidic environment and allows the tumor to become acid resistant. CAIX expression was found in the tumor stroma, as previously reported [29, 54, 59 ] . There was a discrepancy between the results of previous studies regarding the expression of CAIX in the tumor stroma and its implication in the prognosis of breast cancer, thus it was not possible to clarify the role of CAIX expression in the stroma of breast cancer in this study.
In this study, the expression of CAIX in the stroma was the lowest in the TNBC subtype, suggesting that the tumor stroma is acid sensitive in spite of the high CAIX expression, enabling tumor cells of the TNBC subtypes to be acid resistant. It has been reported that increased acidity in the tumor stroma enables tumor invasion through degradation of the extracellular matrix [60] and generation of genetic mutations in the cells [61] , which may be related to the aggressiveness of the TNBC type. The basal-like subtype of TNBC had higher rates of Glut-1 and CAIX expression than the non-basal-like subtype (p = 0.010 and p ! 0.001, respectively) in this study, which is consistent with the results of previous studies that showed that the expression of Glut-1 and CAIX is strongly associated with the basal-like subtype [33, 40] . Although there is some overlap in their characteristics, TNBC and basal-like breast cancers are not coincident entities. TNBC is a heterogeneous tumor group comprised of the basal-like subtype, the molecular apocrine subtype (HER-2 enriched type), and the claudinlow subtype [62] . The basal-like subtype of TNBC showed a more glycolytic and acid-resistant phenotype than the non-basal-like subtype in this study, and this result may be linked to the more aggressive behavior of tumors showing the basal markers of TNBC.
In conclusion, we identified different expression patterns of metabolism-related proteins according to the molecular subtypes of breast cancer defined by surrogate markers. Increased expression of HIF-1 ␣ , IGF-1, and MIF was noted in the HER-2 type, and increased expression of Glut-1 and CAIX was noted in the TNBC type, especially in the basal-like subtype, which had a glycolytic and acid-resistant phenotype.
